iPro® Evaluation

An easy way to obtain more insights into your glucose control.

LOOK CLOSER
INTO YOUR GLUCOSE PROFILE WITH CGM
iPro Evaluation

More Complete Information Can Lead to Better Decisions and Control

A1C and fingersticks alone miss important information:

  • Even if you are in range of your A1C target, it doesn’t mean your glucose is under control
  • Fingersticks can miss up to 80% of potentially dangerous highs and lows that may occur in a given day1
Better Decisions and Control

Get the Complete Picture with an iPro Evaluation

iPro Evaluations use continuous glucose monitoring (CGM). An iPro evaluation will record your glucose 24 hours a day and will provide your healthcare provider with insights into how your diet, medication, and daily activities really affect your glucose levels.

  • Get up to 288 glucose readings per day displayed in a personalized report
  • Identify dangerous lows at night
  • Detect how high your glucose really goes after meals

Benefits to Your Health

Therapy adjustments made with CGM data have been proven to:

  • Reduce the frequency and duration of highs and lows1 2
  • Reduce A1C levels, which can lead to reduced risk of complications3 4

Simple 3-day Assessment of Glucose Levels

You can go about your everyday life while wearing iPro:

  • Get set up in minutes
  • Wear a small and watertight device

Who Can Benefit

An iPro Evaluation can benefit the following individuals1

  • 1. Patients with Type 1 and Type 2 diabetes who:
    • Are not at their A1C target
    • Have recurrent hypoglycemia or hypoglycemic unawareness
  • 2. Children with Type 1 diabetes who:
    • Are changing their diabetes regimen
    • Have low glucose at night
    • Experience the dawn phenomenon and high glucose after meals
  • 3. All pregnant women with Type 1 diabetes
Benefits
Featured Customer Stories
References
  1. Kaufman FR, Gibson LC, Halvorson M, et al. A pilot study of the continuous glucose monitoring system. Diabetes Care. 2001;24(12):2030-2034.
  2. Battelino T, Conget I, Olsen B, et al; and SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomized controlled trial. Diabetologia. 2012:55:3155-3162.
  3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med. 1993;329(14):977-986.
  4. Bergenstal RM, Tamborlande WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-320.
  5. Grunberger G, Bailey TS, Cohen AJ, et al; and AACE Insulin Pump Management Task Force. Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. Endocr Pract. 2010;16(4):746-762.